Re:Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Va...
by maxerickson on Wednesday November 18, 2020 @11:50AM
(#25139017)
Yes, it's likely a net reduction in spending, and then on top of that a bunch of harm and death is prevented. Super cheap.
[ Parent
| on HN ]
There are no comments on this comment yet.